Titan Medical Inc (TMDIF)

[hopefulinvest]

At this point the number of outstanding shares and dilution is not the critical issue. If you don't have money to pay your vendors to produce the hardware and software to get to fda submission the game is over and your investment is lost. The management has done a golden job in turning around the company to get investors to believe in the product and the management team to meet goals and perform. As more physicians have seen the product and meet with the management team confidence has grown to this point where 2018 can produce sizable gains for investors especially when you can still buy the stock at 38 cents.

This company is minimally known outside of the robotic community but when wall street takes an interest the upside will be swift. Just like all R&D companies once the product is proven that is when the real value is generated.